articleTop 1% cited

Calreticulin exposure dictates the immunogenicity of cancer cell death

Nature Medicine · 2006 · Vol. 13(1) · pp. 54–61

Michel Obéid✉(Inserm)Antoine Tesnière(Université Paris-Saclay)François Ghiringhelli(Inserm)Gian María Fimia(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani)Lionel Apétoh(Université Paris-Sud)Jean‐Luc Perfettini(Institut Gustave Roussy)Maria Castedo(Université Paris-Saclay)Grégoire Mignot(Inserm)Theocharis Panaretakis(Institut Gustave Roussy)Noëlia Casares(Inserm)Didier Métivier(Université Paris-Sud)Nathanaël Larochette(Université Paris-Sud)Peter Van Endert(Université Paris Cité)Fabiola Ciccosanti(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani)Mauro Piacentini(University of Rome Tor Vergata)Laurence Zitvogel(Inserm)Guido Kroemer(Institut Gustave Roussy)

View via DOI Publisher page

Endoplasmic Reticulum Stress and Disease Phagocytosis and Immune Regulation Autophagy in Disease and TherapyImmunogenic cell deathImmunogenicityCalreticulinEtoposideImmune systemCancer researchProgrammed cell deathMitomycin CCancer cellBiology

MeSH terms

AnimalsAntigens, DifferentiationAntineoplastic AgentsCell MembraneColonic NeoplasmsDendritic CellsEtoposideMice, Inbred BALB CMice, NudeNeoplasms, ExperimentalPhagocytosisRecombinant ProteinsImmunoblottingElectrophoresis, Gel, Two-DimensionalMitomycin

Citations

3,040

FWCI

31.31

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency